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Abstract
Pneumocystis jirovecii pneumonia (PCP) is a leading cause of morbidity and mortality in immunocompromised patients. Despite the sensi-
tivity of the commonly used PCR for diagnosing P. jirovecii with primers pAZ102-H/pAZ102-E and pAZ102-X/pAZ102-Y derived from
mtLSU rRNA (conventional PCR), some PCP patients who had demonstrable organisms by staining methods failed to give positive
PCR results. Herein, we devised a more sensitive PCR assay derived from the same gene target to circumvent these false-negative tests.
Single brochoalveolar lavage (BAL) samples were collected from human immunodeﬁciency virus (HIV)-infected (n = 66) and non-HIV
(n = 36) immunocompromised patients presenting with fever, dyspnoea, cough and pulmonary inﬁltrates. Pneumocystis jirovecii was diag-
nosed with Giemsa-stained smear, immunoﬂuorescence assay, conventional single-round and nested PCR, and new single-round and
nested PCR in 46 (45.1%), 53 (52.0%), 69 (67.6%), 74 (72.6%), 87 (85.3%) and 91 (89.2%) patients, respectively. The new PCR could
detect P. jirovecii DNA in BAL ﬂuids two to three orders of magnitude more dilute than conventional PCR. Sequence analysis revealed
one to three nucleotide substitutions within the primers for conventional PCR among clinical isolates. Although both conventional and
new PCR assays were highly speciﬁc for diagnosing P. jirovecii, the new PCR yielded more positive results than conventional PCR among
BAL samples that were negative by both Giemsa stain and immunoﬂuorescence assay. Hence, the new PCR offered a more sensitive
detection of P. jirovecii infection and colonization than conventional PCR.
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Introduction
One of the signiﬁcant morbidity and mortality consequences
in immunocompromised patients has been attributable to
Pneumocystis jirovecii pneumonia (PCP) [1]. Despite its cosmo-
politan distribution, the prevalence of PCP seems to exhibit
geographic variation and depend on the population studied
[2,3]. Although microscopy methods conﬁrm both cystic and
trophic stages of P. jirovecii and have the best correlation
with diagnosis of PCP, PCR-based methods that only detect
P. jirovecii DNA display greater sensitivity and correlate with
PCP in patients with acquired immunodeﬁciency syndrome
with an altered radiography [4]. Detection of P. jirovecii DNA
is probably a good indicator of the presence of P. jirovecii
cells in the lung. On the other hand, detection of P. jirovecii
DNA does not necessarily imply the presence of viable and
infectious P. jirovecii organisms. Meanwhile, the diagnostic
performance of microscopy is variable and highly dependent
on quality and type of sample, the number of organisms in
the tested material and the experience of the microscopist
[4].
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One of the attractive gene targets for diagnostic PCR is
the mitochondrial large subunit ribosomal RNA locus (mtLSU
rRNA) of P. jirovecii [4–7]. It is noteworthy that the outer pair
of primers pAZ102-E and pAZ102-H, and the inner pair of
primers pAZ102-X and pAZ102-Y by Wakeﬁeld and col-
leagues targeting mtLSU rRNA of P. jirovecii (henceforth con-
ventional PCR) have been widely used as reference primers
to evaluate the performance of other diagnostic methods [5–
8]. Intriguingly, some isolates of P. jirovecii containing demon-
strable organisms by staining methods failed to be ampliﬁed
by conventional PCR [7,9]. Despite various possibilities gen-
erating false-negative results, sequence variation within the
primers could hinder effective primer-template annealing in a
PCR [10]. To address this issue, we determined the mtLSU
rRNA sequences of P. jirovecii isolates spanning regions used
for conventional PCR primers and assessed the diagnostic
performance of our newly developed PCR assay using bronc-
hoalveolar lavage (BAL) ﬂuids from both human immunodeﬁ-
ciency virus (HIV) and non-HIV immunocompromised
patients.
Materials and Methods
Clinical samples
From June 2006 to May 2009, single BAL samples were col-
lected from 102 immunocompromised patients (46 men, 56
women; mean age 42.4 years) presenting with respiratory
symptoms and pulmonary inﬁltrates at King Chulalongkorn
Memorial Hospital in Bangkok. Of these, 66 patients had HIV
infection with CD4+ lymphocytes < 200/lL and 36 patients
were non-HIV with underlying solid organ malignancies
(n = 14), haematological malignancies (n = 11), systemic
lupus erythematosus (n = 8) and organ transplantation
(n = 3). Each BAL sample (3–5 mL) was brieﬂy vortex-
mixed and divided into 1-mL aliquots. The ethical aspects of
this study have been approved by the Institutional Review
Board of Faculty of Medicine, Chulalongkorn University (IRB
No. 176/51).
Case deﬁnition
Because there is no reference standard for PCP diagnosis,
we deployed both clinical and laboratory criteria for ‘deﬁnite
PCP’ based on the following characteristics: (1) subtle onset
of progressive dyspnoea, non-productive cough and pyrexia,
(2) bilateral interstitial inﬁltration on chest roentgenogram,
(3) clinical response to anti-Pneumocystis treatment, and (4)
presence of P. jirovecii in respiratory samples by Giemsa stain
or immunoﬂuorescence assay (IFA). ‘Probable PCP’ included
those who met all the criteria for ‘deﬁnite PCP’ except that
both Giemsa stain and IFA gave negative results. Patients
who (1) had respiratory symptoms not typical for PCP, (2)
had variant lung inﬁltrations and (3) were responsive to
treatment with other antimicrobial agents or had other deﬁ-
nite diagnosis were deﬁned as ‘non-PCP’. Forty-seven HIV-
positive patients and seven non-HIV patients met all the
criteria for ‘deﬁnite PCP’, three HIV-positive patients and
three non-HIV patients for ‘probable PCP’, and 16 HIV-posi-
tive patients and 26 non-HIV patients for ‘non-PCP’ (pulmo-
nary tuberculosis, n = 16; bacterial pneumonia, n = 6; viral
pneumonia, n = 4; lung cancer, n = 4; lymphoma, n = 4;
aspergillosis, n = 2; ﬁbrotic lung disease, n = 1; systemic scle-
rosis, n = 1; and unknown causes, n = 4).
Morphological diagnosis
Aliquots of BAL ﬂuids from each patient were used for
Giemsa stain and for IFA using the PneunoCell kit (Cellabs,
Sydney, Australia) speciﬁc for trophic and cystic stages of
P. jirovecii. Slides were examined by an experienced micros-
copist who was blinded from the results of other test
methods.
DNA extraction
DNA was extracted from a pellet of each BAL sample using
QIAamp DNA mini kit (Qiagen, Hilden, Germany) following
the instruction manual except for elution with 30 lL TE
buffer.
PCR detection
Nested PCR targeting mtLSU rRNA of P. jirovecii was per-
formed using primers pAZ102-H and pAZ102-E for primary
PCR, and pAZ102-X and pAZ102-Y for nested PCR as
described elsewhere [5,6] (Fig. 1) in a total volume of 20 lL
containing template DNA, 2.5 mM each deoxynucleotide tri-
phosphate, 1.5 lL 10· PCR buffer, 0.3 lM of each primer
and 0.4 units ExTaq DNA polymerase (Takara, Seta, Japan).
Thermal cycling proﬁle for primary PCR included a pre-
ampliﬁcation denaturation at 94C, 2 min; 35 cycles of 94C
for 30 s, 55C for 30 s and 72C for 1 min, and ﬁnal exten-
sion at 72C for 5 min. Nested PCR was performed using
the same thermal cycling proﬁle except annealing at 50C.
All ampliﬁcations were performed in an Applied Biosystem
GeneAmp PCR System 9700 thermocycler (PE Biosystems,
Foster City, CA) and were analysed by 2% agarose gel elec-
trophoresis.
Cloning and sequencing of partial mtLSU rRNA of
P. jirovecii
Because the 5¢ and 3¢ sequences outside the outer PCR
primers by Wakeﬁeld and colleagues remained unknown, we
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used PCR primers derived from Pneumocystis carinii (acces-
sion number GU133622) to obtain the orthologous sequence
of P. jirovecii. The forward and reverse primers were PJLSUF:
5¢-ACCTTTTGCATAATGGGTCAG-3¢ (positions 21664–
21684) and PJLSUR: 5¢-ATTTACTAAATGTTCTGCTACC-3¢
(positions 20986–21007), respectively. The DNA template
was from a P. jirovecii isolate (PJ1 isolate) previously veriﬁed
by the dihydropteroate synthase and dihydrofolate reductase
sequences. Sequence was determined directly and bi-direc-
tionally from PCR-puriﬁed templates.
Development of a new PCR assay
A total of 26 partial mtLSU rRNA sequences of P. jirovecii
retrieved from the GenBank database (Fig. 1) and 12 clinical
isolates whose sequences were determined in this study
were aligned using the CLUSTAL X program [11]. The PCR
primers were derived from conserved region as shown
in Fig. 1. Primers for primary PCR (PJLSUF0:
5¢-TGGCAAATTGTTTATTCCTC-3¢ and PJLSUR0: 5¢-ACT-
GTTCTGGGCTGTTTCCCT-3¢) and nested PCR (PJLSUF1:
5¢-AAATAGTAGGTATAGCACTG-3¢ and PJLSUR1: 5¢-
CTTATCGCACATAGTCTG -3¢) generated 171-base-pair
(bp) and 113-bp products, respectively. Thirty-ﬁve cycles
(94C for 30 s, 55C for 30 s and 72C for 1 min) were per-
formed for primary PCR and 25 cycles for nested PCR. The
products were analysed by 2% agarose gel electrophoresis.
Positive and negative controls
DNA of the PJ1 isolate was used as positive control and
sterile water as negative control. Both these controls were
incorporated in separate reaction tubes for every ten tested
samples. All PCR-negative samples were re-ampliﬁed by
adding positive control to exclude the presence of PCR
inhibitor.
SspI restriction analysis
To reafﬁrm that all PCR products were authentic mtLSU
rRNA of P. jirovecii, the PCR ampliﬁed products were digested
with SspI under the recommended optimal condition
(Takara, Shiga, Japan) and analysed by 3% agarose gel electro-
phoresis.
Speciﬁcity
Speciﬁcities of conventional and new PCR assays were veri-
ﬁed for the lack of cross-ampliﬁcation when DNA of Pneu-
mocystis carinii, Absidia corymbifera, Candida albicans,
Histoplasma capsulatum and Rhizopus oryzae was used as tem-
plate DNA.
P.jirovecii   ACCTTTTGCATAATGGGTCAGCAAGTTAATATGCAATGCAAGTCGCAAGACCTAATGAAGATGAT 65
PJLSUF 
Others    .................................................................  
P.jirovecii TCTGAACAGGGATATAAAGTATTGTGTATTAGACCCGAAATCTAGTGATCTTACTATGATCAGAC 130
Others    .................................................................
P.jirovecii AACTTCAGGTCGAACTGGTGTACGTCGCAAAGTACTCAGAAGAATTGTGGTAAGTAGTGAAATAC 195
pAZ102-H 
Others    .........................T.gc....................................
P.jirovecii
Others    ...a...g...........................-...........................-C
AA
P.jirovecii AAAAATAGTAGGTATAGCACTGAATATCTCGAGGGAGTATGAAAATATTTATCTCAGATATTTAA 325
Ssp I
pAZ102-X 
PJLSUF1 
PJLSUF0 
Others    ................................................................. 
P.jirovecii TCTCAAAATAACTATTTCTTAAAATAAATAATCAGACTATGTGCGATAAGGTAGATAGTCGAAAG 390
Others    ..................................................C..............
P.jirovecii
PJLSUR1
PJLSUR0 pAZ102-Y
Others    ................................T................................
a
P.jirovecii TATCTAAAACAGTTAAGAAGTGGGCTTGGAAACAGCCATCTTTTAAAGAACACGTAAAAGTGCAA 520
Others    .......G.............................c...........................
P.jirovecii TGATCTATGATCTCCAGCGCTGAAAATATCCGGATCTAAATATTATGCTGAAAGACTGTTTATTT 585
pAZ102-E
Others    .................................................................
P.jirovecii TTTTTTTAATTAACTGTAATTTAATTAAAAAAAATAAGGTAGCAGAACATTTAGTAAAT 644
Others    ..C..........A.TAC.G.......................................
PJLSUR
AAATCGGACTAGGATATAGCTGGTTTTCTGCGAAAATTGTTTTGGCAAATTGTTTATTCCTCT-T 260
GGAAACAGCCCAGAACAGTAATTAAAGCTCCCCAATTAATATTAAGTGAAATAAAAGTTGTTGGA 455
FIG. 1. Alignment of the mitochondrial large subunit ribosomal RNA locus (mtLSU rRNA) sequences of Pneumocystis jirovecii (PJ1 isolate) encom-
passing 644-base-pair fragment. ‘Others’ denotes sequences from 12 Thai isolates determined herein and 26 sequences available in the GenBank
database (accession numbers AF337535, AJ608260, EF439813–EF439817, EU917445, EU979566, FJ357841-FJ357852, M58605, S42926, S77824,
S77852 and S79766). Locations of primers for conventional PCR [5,6] and for new PCR are in broken lined and solid lined boxes, respectively.
Dots represent identical nucleotides and dash es represent deletions. Upper case substituted nucleotides indicate occurrence in two or more
sequences. Singleton substitutions are in lower case letters.
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Comparative sensitivities
Ten-fold serial dilutions of P. jirovecii genomic DNA (PJ1 iso-
late) were used as templates to assess the efﬁciency of
ampliﬁcations of both conventional and new PCR assays. The
PCR were performed in quadruplicate for each dilution of
template. Results were determined by analysis of the ampli-
ﬁed products on 2% agarose gel electrophoresis.
Results
Partial mtLSU rRNA sequence
Primers derived from mtLSU rRNA of P. carinii could success-
fully amplify the orthologous gene fragment of P. jirovecii gen-
erating a 643-bp PCR product that spanned 147 bp upstream
to the primer pAZ102-H and 126 bp downstream to the pri-
mer pAZ102-E (Fig. 1). Sequence analysis of 12 clinical iso-
lates in this study and 26 sequences available in the GenBank
database has revealed 16 single nucleotide polymorphisms
and two insertions/deletions (Fig. 1). Intriguingly, all four
primers conventionally used for PCR assay were located in
regions containing single nucleotide polymorphisms, i.e.
three, two, one and one single nucleotide polymorphism in
primers pAZ102-H, pAZ102-X, pAZ102-Y and pAZ102-E,
respectively (Fig. 1). By contrast, no single nucleotide poly-
morphism was observed among Thai isolates and those in
the GenBank database for primers PJLSUF0, PJLSUF1, PJL-
SUR1 and PJLSUR0 developed in this study.
Comparative sensitivity
Under the optimal condition for each PCR assay, the mini-
mum dilutions of genomic DNA of the PJ1 isolate that gave
reproducible positive results for conventional single-round
and new single-round PCR assays were 10)6 and 10)8,
respectively. The minimum dilutions of the same DNA tem-
plate that conferred consistent positive results for conven-
tional nested and new nested PCR were 10)8 and 10)11,
respectively. These data were essentially the same for all
four repeated assays.
Speciﬁcity of the PCR assays
No cross-ampliﬁcation was obtained from both conventional
and new PCR when genomic DNA of P. carinii and some rep-
resentative fungi were used as templates. The mtLSU rRNA
sequence of P. jirovecii determined in this study was distinct
from that of P. carinii with 22% nucleotide differences. There-
fore, substantial nucleotide mismatches between these diag-
nostic primers and mtLSU rRNA of P. carinii plausibly
precluded cross-hybridization in the PCR assay. The ampli-
ﬁed products from all positive samples exhibited speciﬁc
restriction fragments upon SspI digestion (132-bp and 120-bp
fragments for conventional nested PCR and 69-bp and
44-bp fragments for new nested PCR), indicating no false
ampliﬁcation.
Comparative detection of P. jirovecii in BAL samples
Of 102 BAL ﬂuids, Giemsa stain demonstrated characteristic
trophic forms and octonucleate cysts of P. jirovecii in 40
(60.6%) HIV-infected patients and six (16.7%) non-HIV-
infected individuals. The IFA did not increase diagnostic yield
from BAL samples from non-HIV patients whereas seven
additional positive cases were found among HIV-infected
patients (Table 1). Conventional nested PCR gave positive
results 1.40 times more than IFA (1.23 and 2.67 times more
TABLE 1. Comparative detection of Pneumocystis jirovecii by Giemsa stain, immunoﬂuorescence assay (IFA), conventional
PCR and new PCR in bronchoalveolar assay ﬂuids from 102 patients
Result n
Positive results (%)
Giemsa stain IFA
Conventional PCR New PCR
Single-round Nested Single-round Nested
HIV-positive patients 66 40 (60.6) 47 (71.2) 56 (84.9) 58 (87.9) 64 (97.0) 65 (98.5)
Deﬁnite PCP 47 40 (85.1) 47 (100) 46 (97.9) 47 (100) 47 (100) 47 (100)
Probable PCP 3 0 0 2 (66.7) 2 (66.7) 3 (100) 3 (100)
Non-PCP 16 0 0 8 (50.0) 9 (56.2) 14 (87.5) 15 (93.7)
Non-HIV patients 36 6 (16.7) 6 (16.7) 13 (36.1) 16 (44.4) 23 (63.9) 26 (72.2)
Deﬁnite PCP 7 6 (85.7) 6 (85.7) 7 (100) 7 (100) 7 (100) 7 (100)
Probable PCP 3 0 0 3 (100) 3 (100) 3 (100) 3 (100)
Non-PCP 26 0 0 3 (11.5) 6 (23.1) 13 (50.0) 16 (61.5)
Total cases 102 46 (45.1) 53 (52.0) 69 (67.6) 74 (72.6) 87 (85.3) 91 (89.2)
Efﬁcacy ratio
Positives by a given test/Giemsa
positives
1 1.15 1.50 1.61 1.89 1.98
Positives by a given test/IFA
positives
0.87 1 1.30 1.40 1.64 1.72
HIV, human immunodeﬁciency virus; PCP, Pneumocystis jirovecii pneumonia.
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than IFA for HIV-infected and non-HIV patients, respectively)
whereas new nested PCR offered positive tests 1.72 times
more than IFA (1.36 and 4.33 times more than IFA in HIV-
infected and non-HIV immunocompromised patients, respec-
tively). The diagnostic efﬁcacies of conventional nested PCR
and new nested PCR assay conferred 61% and 98% more
positive results than Giemsa stain, respectively (Table 1). All
tests used in this study gave concordant results in 55 BAL
samples (53.9%). New nested PCR yielded the highest posi-
tive results compared with other tests whereas single-round
new PCR offered 13 more positive tests than conventional
nested PCR. No negative PCR samples contained PCR inhibi-
tors because positive results upon re-ampliﬁcations were
obtained when positive control DNA was added.
Clinical relevance of diagnostic methods
Conventional nested PCR and new single-round and nested
PCR assays could detect all samples that were positive by
Giemsa stain or IFA, which could be because of the presence
of P. jirovecii DNA above the PCR detection threshold. How-
ever, conventional single-round PCR failed to detect one iso-
late that was positive by both staining methods. Sequence
analysis of this sample has shown a C/T substitution in the
annealing region for primer pAZ102-H as shown in Figure 1.
Discussion
Conﬁrmation of P. jirovecii by microscopy has been hampered
by the low sensitivity of conventional staining methods
such as Giemsa and methenamine silver stains. Although
subsequent application of immunoﬂuorescence stain has
remarkably increased diagnostic yield, a number of samples
containing a submicroscopic level of P. jirovecii remained undi-
agnosed [9,12,13]. Background ﬂuorescence of some samples
under IFA could lead to false identiﬁcation of the trophic
stage of P. jirovecii [7]. In this study, IFA seems to be more
sensitive than Giemsa stain in HIV-infected patients with pul-
monary symptoms than in non-HIV immunocompromised
hosts. Despite a limited number of samples in this analysis, a
higher proportion of false-negative results from detection
methods based on visualization of organisms were more pro-
nounced in non-HIV patients than in HIV-infected patients
with deﬁnite PCP (Table 1). These ﬁndings were in good
agreement with previous reports that PCP in non-HIV
patients usually had fewer organisms than in HIV-infected
patients [14,15].
The PCR-based method has remarkably facilitated diagnos-
tic efﬁciency, resulting in an increase in the number of docu-
mented PCP cases worldwide [4]. It seems that the
sensitivity of PCR detection depends on copy number of the
gene target; thereby PCR assays that amplify single copy
genes offered similarly concordant results and were less sen-
sitive than the mtLSU rRNA-based PCR assay [7]. However,
the sensitivity of single-round PCR targeting mtLSU rRNA
using the same primer pairs was reportedly lower than
nested PCR targeting ITS and 18S rRNA that are single copy
genes [16]. The extended sequences of mtLSU rRNA of
P. jirovecii obtained in this study have led to identiﬁcation of
nucleotide substitutions in primers pAZ102-H, pAZ102-E,
pAZ102-X and pAZ102-Y among Thai isolates and those
reported in the GenBank database. Importantly, new single-
round and nested PCR were capable of amplifying DNA tem-
plate that were two and three orders of magnitude more
diluted than conventional single-round and nested PCR,
respectively. Although nucleotide substitutions were not
observed at the 3¢ residue of the primers that could be cru-
cial for primer–template annealing before DNA polymeriza-
tion, the occurrence of two or more primer–template
mismatches reportedly reduced the PCR product yield vary-
ing from two-fold to ten-fold compared with the PCR prod-
uct generated from perfectly matched sequences between
primer and template [10,17]. In this study, the sensitivity of
conventional nested PCR containing at least one primer–
template mismatch was 18.7% (17/91) less than that of new
nested PCR whose primers were derived from conserved
sequences (Table 1). Furthermore, a shorter span of target
sequence of new PCR could permit more efﬁcient ampliﬁca-
tion than conventional PCR. Meanwhile, failure to detect
P. jirovecii DNA by PCR in samples that are positive by stain-
ing methods does not necessarily reﬂect sequence variation
in the template DNA because the amount of organisms
could vary among different sources of samples and the meth-
ods for sample processing in the laboratory in addition to
the status of the patients. Furthermore, stochastic distribu-
tion of P. jirovecii in each aliquot of the same sample could
cause such discrepant results.
Multiple lines of evidence indicate that P. jirovecii can colo-
nize the mucosal epithelium of both healthy individuals and
those with compromised immunity [18–20]. Our study has
shown that new nested PCR could detect P. jirovecii DNA in
BAL ﬂuids from non-PCP patients with higher positive rates
among HIV-infected patients than non-HIV patients, suggest-
ing colonization or subclinical infection among these patients.
However, it remains unknown whether P. jirovecii colonizes
HIV-infected patients more often than non-HIV-infected indi-
viduals in a larger sample size and in a different population.
Our PCR assays per se could not differentiate true PCP from
P. jirovecii colonization whereas quantitative real-time PCR
assay has been proven to be useful in discriminating these
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conditions in immunocompromised patients with or without
HIV infection [21,22]. Alternatively, when quantitative real-
time PCR is not available, it would be practical to make a
diagnosis of PCP based on both laboratory results along with
compatible clinical evidence. Taken together, the highly sensi-
tive new PCR assay developed herein could be useful for
reafﬁrming a clinical diagnosis of PCP in immunocompro-
mised patients with consistent respiratory symptoms and
radiographic changes when microscopy fails to detect the
organisms. Furthermore, the method could also be useful for
detecting a very low level of colonization in patients or
otherwise healthy subjects. Deployment of a highly sensitive
diagnostic tool is crucial for ﬁne epidemiological surveillance
and understanding the dynamic of spread of this medically
important ubiquitous microfungus.
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